Description
Durasher (Dapoxetine) 30 mg
Durasher 30 mg is a brand of dapoxetine, an oral film-coated tablet used for premature ejaculation in adult men. Dapoxetine is a short-acting serotonin reuptake inhibitor developed specifically for this condition.
Active Ingredient and Medicine Class
The verified active ingredient is dapoxetine hydrochloride. It belongs to the class of selective serotonin reuptake inhibitors (SSRIs), although it is used here for a urological indication rather than for depression. The product is presented as a 30 mg film-coated tablet.
Established Medical Uses
Dapoxetine is established for the treatment of premature ejaculation in adult men. Regulatory product information describes use in men aged 18 to 64 years. It is intended to help increase the time to ejaculation and improve control over ejaculation.
How It Works
Dapoxetine works by inhibiting the reuptake of serotonin, which helps strengthen serotonergic signalling involved in ejaculatory control. Because it is absorbed and cleared relatively quickly, it is suited to a short-acting, on-demand treatment approach rather than continuous antidepressant use. In clinical studies, this mechanism has been associated with improved ejaculatory latency and better patient-reported control.
Important Safety Information
Dapoxetine should not be used in people with a known allergy to dapoxetine or any tablet ingredient. Regulatory information also lists several important contraindications and precautions, including significant heart rhythm problems, a history of fainting, moderate or severe liver impairment, and a history of mania or severe depression. Clinically important interactions may occur with medicines that affect serotonin or heart rhythm, including monoamine oxidase inhibitors and certain other serotonergic drugs. Caution is also warranted with strong metabolic inhibitors and with medicines that can increase the risk of dizziness, fainting, or serotonin-related adverse effects.
Possible Side Effects
The most commonly reported side effects include nausea, dizziness, headache, somnolence, diarrhoea, and insomnia. Some users may also experience fainting, flushing, or palpitations. More serious reactions are uncommon but require prompt medical attention, especially if there are signs of severe dizziness, collapse, mood changes, or symptoms suggestive of serotonin toxicity.
Scientific Evidence
Human studies and systematic reviews have found that dapoxetine can improve intravaginal ejaculatory latency time and patient-reported control over ejaculation compared with placebo. The evidence base also suggests that the 30 mg and 60 mg strengths have been evaluated in randomised controlled trials, with a generally acceptable safety profile in appropriately selected patients. These findings support its role as a specific oral treatment for premature ejaculation, while also showing that adverse effects can limit tolerability in some men.
Medical Information Notice
This page is an educational summary based on sources available at the time of review. It does not replace the official patient leaflet, the full product information, or assessment by a qualified healthcare professional.
Medical Sources
- European Medicines Agency (EMA). Priligy (dapoxetine) product information / referral materials. View official regulatory document
- electronic Medicines Compendium (emc). Priligy 30 mg film-coated tablets – Patient Leaflet. View patient leaflet
- A Russo et al. Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review. Int J Clin Pract, 2016. View scientific article
- Guo-Jiang Zhao et al. Efficacy and safety of dapoxetine for premature ejaculation: an updated systematic review and meta-analysis. Sex Health, 2019. View scientific article
